Abstract
Phaeochromocytomas and paragangliomas (PPGL) are rare neuroendocrine tumours that arise not only in adulthood but also in childhood and adolescence. Up to 70–80% of childhood PPGL are hereditary, accounting for a higher incidence of metastatic and/or multifocal PPGL in paediatric patients than in adult patients. Key differences in the tumour biology and management, together with rare disease incidence and therapeutic challenges in paediatric compared with adult patients, mandate close expert cross-disciplinary teamwork. Teams should ideally include adult and paediatric endocrinologists, oncologists, cardiologists, surgeons, geneticists, pathologists, radiologists, clinical psychologists and nuclear medicine physicians. Provision of an international Consensus Statement should improve care and outcomes for children and adolescents with these tumours.
| Original language | English |
|---|---|
| Pages (from-to) | 729-748 |
| Number of pages | 20 |
| Journal | Nature Reviews Endocrinology |
| Volume | 20 |
| Issue number | 12 |
| Early online date | 15 Aug 2024 |
| DOIs | |
| Publication status | Published - Dec 2024 |
Bibliographical note
Copyright © Crown 2024, corrected publication 2024. This is an accepted manuscript of an article published in Nature Reviews Endocrinology. The published version is available at: https://doi.org/10.1038/s41574-024-01024-5UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver